Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

The multifocality and irregularity of peritoneal carcinomatosis complicates the within-lesion reproducibility of ADC measurements and the feasibility of accurate serial comparisons. Robust ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Preparations Underway for Phase 3 Ovarian Cancer Trial; Set to Initiate in 1Q25 Imunon, Inc. (NASDAQ:IMNN) previously reported positive topline ...

This single-arm study included 167 patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. The ...

I don’t fully understand why so many people would faint from horror at the thought of hearing a dog screaming in agony but ...

or primary peritoneal cancer, who have previously been treated with between one and three prior systemic treatment regimens can be treated with ELAHERE. ELAHERE was evaluated in the pivotal SORAYA ...

Penn Ovarian Cancer Research Center and Basser Center for BRCA, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States ...

Someone watching over you? This is your lucky day! You’ve got spiritual protection as the moon and Jupiter harmonize. Today’s forecast: zero drama. Why? A guide has your back! A business ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.